Log in to save to my catalogue

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9132770

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Phosphoinositide 3-kinase δ (PI3Kδ) has a key role in lymphocytes, and inhibitors that target this PI3K have been approved for treatment of B cell malignancies
1

3
. Although studies in mouse models of solid tumours have demonstrated that PI3Kδ inhibitors (PI3Kδi) can induce anti-tumour immunity
4
,
5
, its effect on solid...

Alternative Titles

Full title

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9132770

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9132770

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-022-04685-2

How to access this item